Physical Mobility Predictors and the Bone Health in Parkinson’s Disease
Objective: Evaluate the physical mobility and functionality by the ratio of bone mineral density in Parkinson’s disease. Background: Bone loss in Parkinson’s disease (PD) may…Postural control is maintained after a 8-months period of exercise in people with Parkinson’s disease
Objective: Our aim was to investigate the effects of different long-lasting exercises programs on the postural control in people with Parkinson’s disease (PD). Background: Postural…WTX101 – A Novel Copper Modulating Agent for Wilson Disease Demonstrates Efficacy and Safety in a Phase 2, Multi-Center, Open Label Study
Objective: The objective of this study was to evaluate the efficacy and safety of 24 week WTX101 treatment in newly diagnosed Wilson Disease (WD) patients. Background:…A randomized, double-blind, placebo-controlled study of the D1 receptor antagonist ecopipam for children and adolescents with Tourette syndrome
Objective: To investigate the efficacy and safety of the selective dopamine D1 receptor antagonist ecopipam in children and adolescents with Tourette Syndrome (TS). Background: Dysregulation…Association of vitamin D deficiency in Parkinson disease
Objective: To identify the association between vitamin D deficiency and PD in an Arab cohort. Background: A growing body of evidence suggests that vitamin D…PROMESA: Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach – evaluation of serious adverse events
Objective: In the PROMESA trial (ClinicalTrials Identifier: NCT02008721) Epigallocatechingallate (EGCG) a catechine that prevents pathological protein aggregation in vitro and can be purified from green…Effect of Droxidopa Treatment on Fear of Falling in Patients With Neurogenic Orthostatic Hypotension: Clinical Trial and “Real World” Results
Objective: To assess the impact of droxidopa on fear of falling in patients with symptomatic neurogenic orthostatic hypotension (nOH) in 2 studies. Background: nOH results…Interim Results of an Ongoing Open-label Safety Study of ADS-5102 (amantadine hydrochloride) Extended-Release Capsules for Treatment of Levodopa-Induced Dyskinesia (LID) (EASE LID 2 Study)
Objective: Characterize the long-term safety and tolerability of 340 mg of ADS-5102 administered once daily at bedtime, for the treatment of LID in Parkinson’s disease…Parkinsonics – A Prospective, Randomized, Blinded, Cross-Over Trial of Group Singing for Motor and Non-Motor Symptoms in Idiopathic Parkinson Disease (PD)
Objective: To assess the effects of weekly group singing on PD patients’ objective vocal and motoric function, cognition, mood, self-efficacy and quality of life. Background:…Correlation of Electrode Position and Clinical Outcomes in Globus Pallidus Stimulation for Dystonia
Objective: The aim of this study was to determine the discrepancies between the final location of the contacts in the GPi and the targets that…
Abstracts from the International Congress of Parkinson’s and Movement Disorders.